Pragmatic consultancy and
solutions that produce real business benefits
eVantage
Consulting Ltd
is a productivity consultancy,
focusing on the pharmaceutical and healthcare industries. The
company was founded in 2001 by Chris Wiggins and Julian Snape.
Chris
Wiggins
Previously
15 years’ industry experience in sales, marketing and business
intelligence. Prior to founding eVantage with Julian, Chris was
the European Productivity Director for Knoll Pharma. In this
position, Chris was responsible for introducing harmonised
customer management methods, data strategies, and sales &
marketing efficiency benchmarks across the European markets.
Chris has spoken many times at industry meetings in the UK and
across Europe, giving seminars in pharmaceutical productivity
and customer targeting.
Julian Snape
Previously
10 years’ industry experience in sales, marketing and business
intelligence. Prior to forming eVantage, Julian was the Sales &
Marketing Productivity Manager for Knoll Ltd. This role
comprised of managing the CRM processes and initiatives, sales &
marketing reporting and implementing salesforce effectiveness
strategies. Julian has spoken at numerous industry meetings,
including international CRM congresses and at salesforce
effectiveness workshops in the UK.
With this level of
industry experience, we can provide incisive and effective advice
and solutions that will rapidly improve your business.
Having been on the other side of the fence as customers, we can
provide what we, and more importantly our clients believe to be
leading edge consultancy services.
Our mission is simple, to provide the most productive and cost
effective services available.
We have implemented projects with some of the world's biggest
companies and across all the major markets. We are not
limited to the UK and have worked with affiliates across a range
of European countries.
This experience is available to you through our range of services.
"I don't know how they found the hours in the day; the
quality of delivery in the face of aggressive timescales was
staggering"
Novartis UK
|
